APO LXR 500 (Levetiracetam extended release 500 mg)

Pill imprint APO LXR 500 has been identified as Levetiracetam extended release 500 mg.

Levetiracetam is used in the treatment of seizures; epilepsy; bipolar disorder; new daily persistent headache; neuralgia (and more), and belongs to the drug class pyrrolidine anticonvulsants. Risk cannot be ruled out during pregnancy. Levetiracetam 500 mg is not a controlled substance under the Controlled Substance Act (CSA).

Levetiracetam extended release

Imprint:

APO LXR 500

Strength:

500 mg

Color:

White

Shape:

Elliptical / Oval

Availability:

Prescription only

Drug Class:

Pyrrolidine anticonvulsants

Pregnancy Category:

C - Risk cannot be ruled out

CSA Schedule:

Not a controlled drug

Manufacturer:

Apotex Corp.

National Drug Code (NDC):

60505-3280

Inactive Ingredients:

hypromellose 2208 (15000 mPa.s)
silicon dioxide
hypromellose 2910 (5 mPa.s)
hydroxypropyl cellulose
polyethylene glycol 8000
titanium dioxide
water

Note: Inactive ingredients may vary.

Imprint Code FAQ's

Other Manufacturers / Repackagers:

NDC Code	Manufacturer / Repackager
60429-0349	Golden State Medical Supply (repackager)

More info Print Imprint Search

Disclaimer: Every effort has been made to ensure that the information provided is accurate, up-to-date, and complete, but no guarantee is made to that effect. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.

Copyright 2017 Drugs.com, National Library of Medicine, Truven Health Analytics and Cerner Multum, Inc. All Rights Reserved.